Personalized assessment and management of women at risk for breast cancer in North America

Womens Health (Lond). 2015 Mar;11(2):213-23; quiz 223-4. doi: 10.2217/whe.14.79.

Abstract

Many women at increased risk for breast cancer would benefit from referral for genetic testing, enhanced screening, preventive therapy or risk-reducing surgery. We present a visual model and a step-wise approach to assist with a personalized risk stratification and management of these women. We present current recommendations with respect to lifestyle behaviors and mammographic screening, and we review the current evidence regarding enhanced screening and risk-reducing therapies. We discuss the usefulness of three risk-assessment tools in determining whether a woman qualifies for genetic testing, enhanced screening or preventive therapy and present four cases to demonstrate the usefulness of this approach in the clinical setting.

Keywords: breast cancer; genetic testing; intensive screening; preventive therapy; risk assessment; risk calculators; risk-reducing surgery.

Publication types

  • Review

MeSH terms

  • Aromatase Inhibitors / administration & dosage
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Health Behavior
  • Humans
  • Life Style
  • Magnetic Resonance Imaging
  • Mammography
  • Mastectomy / methods
  • North America
  • Primary Prevention / methods
  • Risk Assessment
  • Risk Factors
  • Selective Estrogen Receptor Modulators / administration & dosage

Substances

  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators